An Informational Buyer’s Guide to 10:1 Fruiting Body Extracts, Immune Support, Cognitive Clarity, and What Quality Labels Reveal About Chaga, Turkey Tail, and Maitake Formulas

Homewood, IL, Dec. 27, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting supplements. If you purchase through links in this article, a commission may be earned at no additional cost to you. This article is an informational industry analysis based on publicly available product information and company disclosures. It is not medical advice, and it does not recommend or endorse any supplement for any individual outcome. Where scientific studies are discussed, they relate to ingredient-level research rather than clinical testing of the finished product. Individual results vary significantly based on numerous factors including baseline health status, lifestyle, and consistency of use.

Readers can View the current Mushroom Gummies offer (official Pilly Labs page) to confirm current availability and label details.

In this analysis, “best” refers to disclosed formulation standards that consumers commonly compare when evaluating mushroom gummy products, including fruiting body sourcing, extract concentration ratios, manufacturing certifications, and label transparency. This usage does not imply guaranteed results or superiority claims.

Throughout this article, the term “best” is used strictly as a comparative framework for evaluating disclosed product characteristics, not as a recommendation, guarantee, or prediction of results.

Learn more byViewing the current Mushroom Gummies offer (official Pilly Labs page) to confirm current availability and label details.

Related Industry Coverage: Previous informational analysis of functional mushroom supplementation is available at Industry Analysis: Pilly Labs Mushroom Supplement Evaluation and Mushroom Gummies for Anxiety Support and Stress Relief Analysis

Why “Best Mushroom Gummies” Is Trending Into 2026

If you’ve been researching functional mushroom supplements lately, you’re not alone. Consumer attention toward this category continues to grow as the 2026 New Year wellness season begins, with search interest in mushroom-based cognitive support, immune health, and natural energy alternatives climbing as people explore plant-based wellness options for the year ahead.

The functional mushroom supplement category has expanded significantly, with gummy formats gaining particular traction among consumers who prefer convenient delivery methods over capsules or powders. This growth reflects broader interest in adaptogenic supplementation and natural wellness approaches – and if you’re reading this, you’re likely part of that trend.

Here’s the challenge: increased consumer interest has produced a wide range of product options with varying quality standards. Product quality and formulation standards can vary widely across this category, which is why understanding how to evaluate labels and disclosures matters. This analysis examines the criteria that informed consumers commonly evaluate when comparing mushroom gummy products, using Pilly Labs Mushroom Gummies as a reference example based on publicly available product information.

The 5 Criteria That Separate Quality Mushroom Gummies From the Rest

When evaluating mushroom gummy products, informed consumers typically examine five key factors. Understanding these criteria helps you make your own informed decision based on your individual needs and preferences – and helps you spot products that may not deliver what their marketing suggests.

Criterion 1: Fruiting Body vs. Mycelium-on-Grain Sourcing

This distinction is one of the most commonly discussed sourcing variables in the mushroom supplement category and can affect what a product contains.

The fruiting body is the visible part of the mushroom – the cap and stem you’d recognize if you saw it growing. This portion contains the highest concentrations of compounds that research has examined, including beta-glucans, triterpenes, and species-specific constituents like hericenones in Lion’s Mane. When supplements specify “fruiting body,” they indicate use of this portion of the mushroom.

Mycelium-on-grain products involve growing mushroom mycelium on grain substrates like rice or oats. The resulting product contains both mycelium and the grain substrate. Because mycelium can be cultivated on grain-based substrates, some products in the category may contain varying proportions of mycelium and grain substrate depending on how they are produced and labeled. In practical terms, this can affect the proportion of mushroom-derived compounds relative to the grain substrate included in the final product.

Neither approach is inherently “right” or “wrong,” but the distinction affects what you actually receive. Products that specify fruiting body sourcing provide transparency about this important factor – and when sourcing details are not specified, consumers may have less information to evaluate that aspect of the product.

Criterion 2: Extract Ratio Disclosure

Extract ratios indicate the concentration level of mushroom extracts. A 10:1 ratio, for example, indicates that 10 parts of raw mushroom material yield 1 part of concentrated extract. Higher concentration ratios generally indicate more potent extracts, though optimal ratios may vary by mushroom species and intended application.

Products that disclose extract ratios provide you with information to compare concentration levels across different options. Products without disclosed ratios leave you unable to evaluate this factor – and in a category where concentration matters, that opacity should raise questions.

Criterion 3: Species Selection and Multi-Mushroom Formulations

Different mushroom species contain different compound profiles and have been examined in research for different potential applications. Lion’s Mane research has explored cognitive-related compounds. Cordyceps research has examined energy and endurance markers. Reishi research has explored stress-response and immune-related pathways. Chaga research has examined antioxidant properties.

Multi-mushroom formulations combine multiple species, potentially providing broader compound coverage than single-species products. Single-species products may provide higher concentrations of specific mushrooms. Neither approach is universally superior – the choice depends on your individual goals and preferences. What matters is that you understand what you’re getting and why.

Criterion 4: Manufacturing Standards and Certifications

Manufacturing certifications provide baseline quality assurance indicators. GMP (Good Manufacturing Practices) certification indicates adherence to standardized production protocols. FDA-registered facilities operate under regulatory oversight frameworks. U.S.-based manufacturing provides supply chain transparency for domestic consumers.

These certifications do not constitute FDA approval of efficacy claims, but they do indicate baseline manufacturing quality standards. A product manufactured in a certified facility isn’t guaranteed to work for you – but a product manufactured without these standards introduces unnecessary uncertainty.

Criterion 5: Testing Transparency and Label Accuracy

Third-party testing involves independent laboratory verification of product contents. Products that undergo third-party testing and make Certificates of Analysis (COAs) available provide you with independent verification of label claims.

Transparent labeling includes clear ingredient disclosure, allergen warnings, and accurate representation of product contents. Products that clearly disclose what they contain and how they are manufactured provide the information you need to make an informed decision. Products that use proprietary blends or vague sourcing statements may provide less detail for consumers who prefer to compare labels and disclosures.

Where Pilly Labs Mushroom Gummies Align With These Criteria

Based on publicly available product information from the official Pilly Labs website, this section examines how Pilly Labs Mushroom Gummies align with the quality criteria outlined above. All product claims in this section are attributed to company disclosures and have not been independently verified by this publication.

Fruiting Body Sourcing

According to the product page, Pilly Labs Mushroom Gummies use fruiting body extracts rather than mycelium-on-grain formulations. The company states that the product contains “10 premium fruiting body mushroom extracts.” This aligns with the fruiting body criterion that many consumers evaluate when comparing products.

Extract Concentration

The product page states that Pilly Labs Mushroom Gummies use “10:1 concentration” extracts. According to the company, this means “10 pounds of raw mushroom material are concentrated into 1 pound of extract.” This disclosed ratio provides concentration information for comparison purposes.

Species Selection

According to publicly available product information, the formula includes 10 mushroom species: Lion’s Mane, Reishi, Cordyceps, Chaga, Turkey Tail, Maitake, Shiitake, Royal Sun Agaricus, White Button, and Black Fungus. The product page describes this as a multi-species approach designed to provide coverage across cognitive, immune, energy, and stress-response dimensions.

Manufacturing Standards

The company states that products are “manufactured with FDA-registered, GMP-certified partners in the United States.” According to the product page, “full ingredient disclosure” is provided on every bottle. These statements indicate alignment with manufacturing transparency criteria, though they do not constitute independent verification.

Testing and Transparency

The company states that products undergo third-party testing for purity and potency. The product page provides detailed ingredient information and allergen warnings. Consumers seeking verification can request Certificates of Analysis directly from the company.

Additional Product Characteristics (As Stated)

According to the product page, the gummies are described as vegan, non-GMO, gluten-free, and free from artificial additives. The company states that the gummy base uses pectin (a plant-derived gelling agent) rather than gelatin, and natural raspberry flavoring.

The product page also notes that the product is “manufactured in a facility that processes common allergens (milk, soy, wheat, egg, peanuts, tree nuts, fish, and shellfish).” If you have allergies, review complete label information before purchasing.

Readers can View the current Mushroom Gummies offer (official Pilly Labs page) to confirm current availability and label details.

What the Research Says About These Ingredients

The mushroom species included in Pilly Labs’ formula have been examined in various research contexts. The following summarizes ingredient-level research and does not represent claims about the finished product. Research on individual ingredients does not prove outcomes for any specific gummy product – but understanding what researchers have explored helps you evaluate whether these ingredients align with your wellness goals.

Lion’s Mane (Hericium erinaceus)

Research has explored Lion’s Mane for compounds called hericenones and erinacines. Studies have examined these compounds for potential effects on nerve growth factor production in laboratory settings. Some research in older adults has examined associations between Lion’s Mane supplementation and cognitive test scores. This research relates to the ingredient, not to any specific commercial product.

Reishi (Ganoderma lucidum)

Research has examined Reishi for triterpenes and beta-glucan compounds. Studies have explored potential associations with stress-response markers and immune function parameters. Traditional use of Reishi spans centuries in various cultural contexts. This research relates to the ingredient, not to any specific commercial product.

Cordyceps (Cordyceps militaris)

Research has examined Cordyceps for potential effects on oxygen utilization and exercise endurance markers. Studies have explored adenosine-related compounds and their potential role in cellular energy pathways. This research relates to the ingredient, not to any specific commercial product.

Chaga (Inonotus obliquus)

Research has examined Chaga for antioxidant properties, with studies measuring ORAC (Oxygen Radical Absorbance Capacity) values. Traditional use in Northern European and Russian contexts has been documented. This research relates to the ingredient, not to any specific commercial product.

Turkey Tail (Trametes versicolor)

Research has examined Turkey Tail for PSK and PSP polysaccharides and their potential immune-related properties. Studies have also explored prebiotic activity and gut microbiome interactions. This research relates to the ingredient, not to any specific commercial product.

Maitake, Shiitake, Royal Sun Agaricus, White Button, and Black Fungus

Each of these species has been examined in various research contexts for beta-glucan content, potential immune-supportive properties, and other characteristics. Research findings relate to the ingredients themselves, not to any specific commercial product formulation.

Important Research Context

The studies referenced examine individual mushroom ingredients under various research conditions. Pilly Labs Mushroom Gummies as a finished product has not been independently clinically studied in published randomized controlled trials. The presence of researched ingredients does not guarantee specific outcomes for any individual consumer. Your results may differ from what research suggests – or you may experience no noticeable benefit at all. That’s the honest reality of any supplement.

Is This Product Right for You?

People evaluating functional mushroom gummy products often include those exploring natural approaches to wellness goals related to mental clarity, focus, energy, immune function, or stress management. The category appeals to consumers interested in plant-based supplementation and adaptogenic approaches.

Who should consult a healthcare provider before using any mushroom supplement:

If you take prescription medications – particularly blood thinners (some mushrooms may have blood-thinning properties), diabetes medications (some mushrooms have been studied for metabolic-related effects), or immunosuppressants (some mushrooms have been studied for immune-modulating properties) – talk to your doctor first.

Additional groups who should seek professional guidance include pregnant or nursing individuals, those with existing health conditions, individuals scheduled for surgery, and anyone under 18 years of age.

Who this product category is NOT for:

If you’re seeking treatment for a medical condition, consult a licensed healthcare professional for personalized guidance. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. If you have a health concern that requires treatment, see a healthcare provider.

How to Evaluate Claims Responsibly

Informed consumers approach supplement marketing with appropriate skepticism. The following framework helps you evaluate mushroom gummy products and their associated claims – including this one.

What Labels Can and Cannot Legally Claim

Under the Dietary Supplement Health and Education Act (DSHEA), dietary supplements may include “structure-function claims” describing how ingredients support normal body functions. Supplements cannot legally claim to diagnose, treat, cure, or prevent diseases. The required FDA disclaimer (“These statements have not been evaluated by the Food and Drug Administration…”) indicates that efficacy claims have not been FDA-verified.

Products making disease claims or promising specific medical outcomes may be operating outside regulatory boundaries – and that should concern you.

What Third-Party Testing Can and Cannot Indicate

Third-party testing can verify that products contain what labels claim and are free from specified contaminants. Third-party testing does not verify efficacy or guarantee results. You can request Certificates of Analysis from manufacturers to review testing documentation.

Why Results Vary

Individual responses to any supplement vary based on numerous factors including baseline health status, existing diet and lifestyle, consistency of use, genetic factors, concurrent medications, and other individual variables. No supplement produces identical results for all users, and some users may experience no noticeable benefit despite consistent use. Anyone promising guaranteed results is not being honest with you.

Questions to Ask Before Purchasing Any Mushroom Gummy

Does the product specify fruiting body or mycelium sourcing? What extract concentration ratios are disclosed? What manufacturing certifications does the company claim? Is third-party testing conducted, and are results available? What is the return or satisfaction guarantee policy? Have you consulted a healthcare provider about potential interactions with your current medications or conditions?

These questions apply to Pilly Labs and every other product in this category. Informed consumers ask them all.

Product Availability and Company Information

According to the company website, Pilly Labs Mushroom Gummies are available in various package options. Availability, pricing, and promotional terms may vary and should be verified directly through the official website. The company offers a satisfaction guarantee policy; details should be confirmed at the time of purchase.

Readers can View the current Mushroom Gummies offer (official Pilly Labs page) to confirm current availability and label details.

Company Contact Information

Company: Pilly Labs LLC Email: [email protected] Website: https://pillylabs.com Location: Homewood, Illinois, United States

Additional Industry Coverage

For related informational analysis, readers may reference:

Pilly Labs Mushroom Gummies: Sleep and Weight Wellness Category Analysis

Functional Mushroom Gummy Evaluation: Reddit Community Perspectives

Mushroom Gummies vs Chaga: Format Comparison Analysis

Disclaimers

FDA Health Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult your physician before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. Pilly Labs Mushroom Gummies is a dietary supplement, not a medication. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any new supplement.

Results Disclaimer: Individual results will vary based on factors including age, baseline health status, diet quality, exercise habits, sleep patterns, stress levels, consistency of use, and other individual variables. The research cited throughout this article reflects ingredient-level studies conducted with various formulations and dosages. Pilly Labs Mushroom Gummies as a finished product has not been independently clinically studied. Results are not guaranteed.

FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy or integrity of the information presented.

Pricing and Availability Disclaimer: Product availability, pricing, package options, and promotional terms may change without notice. Always verify current details on the official Pilly Labs website before making purchase decisions.

Product Claims Disclaimer: All product features, benefits, ingredients, and specifications described in this article are attributed to publicly available information from the Pilly Labs website and company communications. These claims have not been independently verified by this publication. The publisher does not independently verify product claims, and results are not guaranteed.

Publisher Responsibility Disclaimer: The publisher has made reasonable efforts to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, changes to product formulations, changes to company policies, or outcomes resulting from the use of information provided. Readers are encouraged to verify all details directly with the company and their healthcare provider before making decisions.

Interaction Warning: According to product information, some mushrooms in this formula may interact with certain medications. The company advises consulting healthcare providers before use if taking blood thinners, diabetes medications, or immunosuppressants.

Industry Analysis Published: December 27, 2025

Content Category: Dietary Supplements – Functional Mushrooms – Informational Industry Analysis

Regulatory Framework: DSHEA supplement regulations, FTC endorsement guidelines, FDA dietary supplement guidance

Tags

Best Mushroom Gummies 2026, Functional Mushroom Supplements, Mushroom Gummies Industry Analysis, Pilly Labs, Fruiting Body Mushroom Extract, Lion’s Mane Gummies, Adaptogenic Supplements, New Year Wellness 2026, Mushroom Supplement Quality Criteria, 10-Mushroom Complex

Related Links

Readers can View the current Mushroom Gummies offer (official Pilly Labs page) to confirm current availability and label details.

Contact Data

Company: Pilly Labs LLC Email: [email protected] Website: https://pillylabs.com

CONTACT: Email: [email protected]

In the relentless pursuit of unraveling the complexities of obesity treatment, resveratrol—a naturally occurring polyphenol found predominantly in grapes and red wine—has emerged as a promising candidate due to its purported metabolic and anti-inflammatory properties. However, despite its popularity as a dietary supplement, the definitive effects of resveratrol on key anthropometric indices such as body weight, body mass index (BMI), and waist circumference, as well as on metabolic regulators like adiponectin and leptin, remain mired in uncertainty. A groundbreaking study published in the International Journal of Obesity in late 2025 offers a sweeping evaluation, synthesizing evidence from randomized controlled trials to clarify resveratrol’s impact on individuals with overweight and obesity.

This comprehensive systematic review and meta-analysis, led by Setayesh, Arzhang, Baniasadi, and colleagues, represents one of the most graded and rigorous aggregations of clinical data to date. By meticulously assessing trials that administered resveratrol supplements in varying dosages and durations, the research aimed to distill a coherent understanding of its physiological effects. The rationale is rooted in the biochemical roles of adiponectin and leptin—two adipocyte-derived hormones critical for regulating energy balance and glucose metabolism. Elevated leptin levels, often accompanied by leptin resistance, correlate with obesity, while adiponectin is generally thought to exert protective metabolic effects.

Contrary to the hopeful prospect that resveratrol might meaningfully reduce body mass or favorably modulate these hormones, the analysis reveals an inconclusive landscape. The aggregate data failed to demonstrate statistically significant improvements in anthropometric markers or consistent hormonal shifts across the studied populations. These findings cast a nuanced light on the often overstated benefits of resveratrol supplementation, suggesting that any potential metabolic advantages may be context-dependent or require more prolonged intervention periods to manifest.

Diving deeper, the investigators highlighted the variability in study methodologies as a formidable obstacle in reaching definitive conclusions. Studies included in the meta-analysis varied widely in terms of resveratrol dosage, ranging from modest 150 mg daily intakes to as high as 2 grams, with intervention durations spanning weeks to several months. This heterogeneity inevitably confounds efforts to extrapolate a universal therapeutic guideline. Moreover, participant characteristics such as baseline metabolic health, age, and concurrent lifestyle factors were inconsistently accounted for, adding to the interpretational challenges.

An additional layer of complexity lies in the pharmacokinetics of resveratrol itself. Despite demonstrated efficacy in preclinical models, including rodent studies showing significant reductions in adiposity and improvements in insulin sensitivity, human metabolism of resveratrol is notoriously rapid, leading to low bioavailability. This metabolic reality raises questions about whether the oral supplementation regimens applied in human trials achieve adequate systemic concentrations to replicate the preclinical benefits observed.

The researchers critically examined alterations in circulating adiponectin and leptin levels, given their pivotal roles in obesity pathophysiology. While some individual trials reported mild elevations in adiponectin or reductions in leptin, these effects were not consistently replicated across the pooled data set. Notably, the timing of these hormonal measurements post-supplementation emerged as a possible confounder, along with the sensitivity of assay methodologies employed, which may contribute to statistical noise obscuring true biological shifts.

Interestingly, the meta-analysis underscores the need to redefine endpoints when investigating nutraceutical interventions for obesity. Traditional anthropometric measures alone may insufficiently capture subtle metabolic modulations, thus prompting a call for integrating advanced biomarkers and imaging modalities in future studies. The authors propose longitudinal designs encompassing metabolic flux analyses and tissue-specific assessments to better elucidate resveratrol’s bioactivity profile.

In parallel, the interplay between resveratrol and the gut microbiome has been spotlighted in burgeoning research yet remains underexplored within clinical trials. Emerging evidence suggests that modulation of gut microbial composition could influence host metabolism and adipokine secretion, potentially serving as an indirect mechanistic route for resveratrol’s actions. Future investigations that holistically incorporate host-microbe interactions may unlock novel therapeutic avenues.

Beyond metabolic parameters, resveratrol’s anti-inflammatory and antioxidant effects, documented extensively in vitro and in animal models, invite ongoing scrutiny. Understanding whether these properties translate into systemic benefits for human patients with obesity—who often bear a chronic low-grade inflammatory burden—is crucial. The current meta-analysis underscores the paucity of robust data linking supplementation to improvements in inflammatory biomarkers, reinforcing the thesis that resveratrol’s clinical impact may be more modest than popularly perceived.

The translational gap between promising preclinical insights and equivocal clinical outcomes is emblematic of broader challenges in obesity pharmacotherapy. Precious few compounds achieve meaningful efficacy without adverse effects, underpinning the imperative for rigorous, large-scale human trials with standardized protocols. This meta-analysis, by synthesizing extant data, serves as a clarion call for harmonizing research methodologies to advance evidence-based recommendations.

Moreover, the socio-behavioral dimensions of obesity intervention should not be underestimated. The allure of supplement-based solutions like resveratrol often eclipses fundamental lifestyle modifications that consistently demonstrate robust efficacy. Recognizing supplements as adjunctive rather than primary therapeutic agents is vital in public health messaging.

The study’s authors also advocate for personalized medicine approaches to identify potential responders—subpopulations with distinct genetic, metabolic, or epigenetic profiles who might derive greater benefit from resveratrol. Such stratification could optimize therapeutic outcomes and mitigate blanket assumptions about supplement efficacy.

Ultimately, this meta-analytic work illuminates the intricate and multifactorial nature of obesity management. While resveratrol holds biochemical promise, its role as a standalone intervention remains unsubstantiated by current clinical evidence. The findings encourage tempered optimism and underscore the necessity of multi-dimensional approaches incorporating diet, exercise, pharmacology, and possibly targeted nutraceuticals.

With obesity rates climbing globally, the imperative for efficacious, accessible, and safe interventions is paramount. The evolving evidence base around resveratrol supplementation contributes a critical piece to this complex puzzle, informing both clinicians and individuals seeking scientifically grounded guidance amid a sea of health claims.

As research continues to unfold, the integration of cutting-edge omics technologies and longitudinal cohort studies will be instrumental in dissecting the nuanced interactions between resveratrol, adipose tissue biology, and systemic metabolism. These future endeavors may ultimately clarify whether resveratrol can be harnessed as a valuable component within the comprehensive therapeutic armamentarium against obesity.

For now, it remains clear that despite the decades of enthusiasm surrounding this polyphenolic compound, resveratrol is not a panacea. Nonetheless, its biological potency and safety profile warrant continued investigation under stringent clinical frameworks to fully elucidate its potential and limitations in human metabolic health.

Subject of Research: The impact of resveratrol supplementation on anthropometric indices and adipocyte-derived hormone levels in individuals with overweight and obesity.

Article Title: The effect of resveratrol supplementation on anthropometric indices, adiponectin and leptin levels in individuals with overweight and obesity: a graded, systematic review and meta-analysis of randomized controlled trials.

Article References:
Setayesh, A., Arzhang, P., Baniasadi, M.M. et al. The effect of resveratrol supplementation on anthropometric indices, adiponectin and leptin levels in individuals with overweight and obesity: a graded, systematic review and meta-analysis of randomized controlled trials. Int J Obes (2025). https://doi.org/10.1038/s41366-025-01994-0

Image Credits: AI Generated

DOI: 10.1038/s41366-025-01994-0 (Published 27 December 2025)

Tags: adiponectin and leptin relationshipbody mass index and resveratroldietary supplements for obesitymetabolic impact of resveratrolmetabolic syndrome and polyphenolsobesity treatment innovationspolyphenols and obesity treatmentrandomized controlled trials on weight managementred wine health benefitsresveratrol hormonal regulationresveratrol weight loss effectssystematic review on resveratrol

Ashwagandha is an herb that has many applications in Ayurvedic medicine, based on its purported anti-anxiety, anti-inflammatory, antioxidant, and memory-enhancing properties. Although studies show potential benefits, there isn’t enough robust research to say whether ashwagandha actually improves all the conditions people use it for.

Ashwagandha has been used for hundreds of years in Ayurverdic medicine, but its popularity has skyrocketed since adaptogens entered the wellness market. Adaptogens are herbs and plants that may help your body adapt to stress.

Some research supports that ashwagandha supplements may help reduce stress and anxiety. A small 2019 study of 58 people found that those who took 250-600 milligrams of ashwagandha extract for eight weeks had less perceived stress and lower levels of the stress hormone cortisol.

Other small studies of people who took ashwagandha for 60 days found that the supplement reduced symptoms of anxiety and stress.

However, a 2021 review of preclinical and clinical studies concluded that there’s not enough evidence to determine the right dosage and form of ashwagandha for treating stress and anxiety.

Results from a few clinical trials suggest that taking ashwagandha may help improve sleep.

As you sleep, you progress through a series of sleep cycles, each made up of distinct sleep stages. Having interrupted sleep is disruptive to your sleep cycle, potentially causing you to need more sleep than the standard eight hours to feel restored.

A 2021 review of five studies found that taking an ashwagandha supplement in doses of 250-600 milligrams per day had a small but significant effect on improving sleep compared to a placebo. These benefits were greatest when the dosage was 600 milligrams a day and when participants took the supplement for at least eight weeks.

A 2022 study also suggests that, at a dosage of 700 milligrams per day, ashwagandha extract may significantly improve energy levels.

Some research has shown that ashwagandha may play a role in improving athletic performance. A 2020 review found that taking ashwagandha significantly improved the maximum oxygen consumption (VO2 max) in healthy adults and athletes, which can contribute to improved aerobic ability.

Ashwagandha may have some properties that make it a helpful complement to diabetes treatment. A review published in 2024 found that clinical evidence is limited, but some studies suggest that compounds found in ashwagandha, called withanolides, may help protect against insulin resistance and improve HbA1c levels in people with diabetes.

Ashwagandha may help improve aspects of male infertility. A 2018 review of four clinical trials found that participants with symptoms of infertility who took ashwagandha saw improvements in areas including sperm concentration and motility, semen volume, and testosterone level.

Researchers reported no harmful side effects, either. However, they note that these promising results don’t have enough evidence to fully support this benefit and that more clinical trials are needed.

A study published in 2017 suggests that taking ashwagandha may help protect or improve aspects of cognitive function in adults with mild impairment. These aspects include:

• Memory: Your brain’s ability to store and access information and experiences
• Executive function: Allows for planning, problem solving, decision making, and goal-directed behavior
• Attention: The ability to focus and concentrate on something selectively
• Information processing speed: How quickly you can take in and use or respond to information

Participants took a twice-daily dose of 300 milligrams of ashwagandha root extract for eight weeks, which researchers found both safe and effective.

Some research suggests that ashwagandha may be most effective when taken consistently for at least eight weeks. It’s best to check with a doctor before adding a new supplement to your diet. Your doctor can help determine the proper dosage for your overall health and for the benefits you’re interested in achieving.

With your doctor’s guidance, consider adding ashwagandha powder or extract to your coffee, blending it into a smoothie, or mixing it into oatmeal. Ashwagandha is also available as tablets or capsules you can take by mouth.